Amgen (AMGN) Tuesay announced plans to invest over $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California.
"At Amgen, we're continuing to invest in the future of American science and innovation," said Robert A. Bradway, chairman and chief executive officer at Amgen. "This new center will empower our scientists with the tools and collaborative environment they need to shape the next era of scientific discovery and advance medicines that improve human health."
The new center for science and innovation enhances the company's global network of sites, leveraging decades of operational expertise and technological advancements.
Construction is expected to begin in third quarter of 2025 and create hundreds of U.S. jobs.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.